Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02119299 · ClinicalTrials.gov registry record · NA
Safety and Efficacy of the SMART Device for Overweight and Obese Adults
A NA study of Overweight and Obesity, sponsored by Scientific Intake Limited.
- Completed
- Registry status
- NA
- Development phase
- 76
- Enrollment target
- 4
- Study locations
NCT02119299: Completed NA study of Overweight and Obesity, sponsored by Scientific Intake Limited.
NCT02119299 is a NA study of Overweight and Obesity that has completed, run by Scientific Intake Limited. The registered enrollment target is 76 participants, below the 228-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (67% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02119299, a NA study of Overweight and Obesity, has completed, sponsored by Scientific Intake Limited.
- COMPLETED
- Registry status
- NA
- Development phase
- 76 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of this study is to demonstrate that (1) we will observe at least 40% of the subjects in the Per Protocol population having a measured ≥5% weight loss at 16 weeks compared to week 0; and (2) the observed mean % Total Body Weight Loss at 16 weeks compared to Week 0 is ≥4% in the Per Protocol population.
Conditions Studied
Interventions
- DEVICE SMART device
Study Locations (4)
California
- Investigative Site - San Diego
Connecticut
- Investigative Site - Waterbury
Florida
- Investigative Site - Coral Gables
Texas
- Investigative Site - Sugar Land
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2014-03 |
| Est. Completion | 2015-01 |
| Phase | NA |
What the finished NCT02119299 record still lists
NCT02119299 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 76 participants, a relatively small participant target, below the 228-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (67% lower).
The record links to 1 condition, with Overweight and Obesity appearing as the primary indexed condition, and to 1 intervention - of which SMART device is the first listed.
NCT02119299 reports a single indexed study location in California, Connecticut, Florida.
Frequently Asked Questions
What is clinical trial NCT02119299 about?
NCT02119299 is a clinical study titled "Safety and Efficacy of the SMART Device for Overweight and Obese Adults". The purpose of this study is to demonstrate that (1) we will observe at least 40% of the subjects in the Per Protocol population having a measured ≥5% weight loss at 16 weeks compared to week 0; and (2) the observed mean % Total Body Weight Loss at 16 weeks compared to Week 0 is ≥4% in the Per Proto...
What is the current status of trial NCT02119299?
This trial is currently completed. It is a NA study. The enrollment target is 76 participants. The study started on 2014-03. Estimated completion is 2015-01.
What conditions does trial NCT02119299 study?
This clinical trial studies the following conditions: Overweight and Obesity.
What interventions are being tested in trial NCT02119299?
The interventions under investigation include: SMART device (DEVICE).
Who is sponsoring clinical trial NCT02119299?
This trial is sponsored by Scientific Intake Limited, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02119299 being conducted?
This trial has 4 study locations across California, Connecticut, Florida, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Overweight and Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02119299's enrollment target sits among peer trials
76 67th of 115 higher than 49 of 115 other Overweight and Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Overweight and Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Dose Response Effects of Pecan Consumption
RECRUITING · NA
-
A Pilot Factorial Trial of an Integrated Lifestyle Intervention
RECRUITING · NA
-
Cottonseed Oil Dose Response
RECRUITING · NA
-
Cooking Skills to Improve Long-Term Weight Loss in Young Adults With Intellectual Disabilities
RECRUITING · NA
-
Testing the Adipose Expandability Hypothesis in Vivo During Overfeeding
RECRUITING · NA
-
Cottonseed Oil Versus Matched PUFA Effects
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02615184 · 76 participants · Phase 2
A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old
- NCT02821741 · 76 participants · NA
Effects of External Ear Stimulation on Pain Perception and Mood
- NCT03019757 · 76 participants
Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease
- NCT03353584 · 76 participants · NA
Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia